Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SSNC✓SelectedUSD · SSNCGSK vs SSNC performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs SSNC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
SSNC return
+158.9%
Excess return
-56.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSSNCExcessAlpha
1D-1.3%-2.9%+1.6%-0.7%
7D-3.1%-4.2%+1.1%-2.2%
30D-0.9%-10.0%+9.2%+1.3%
3M-4.2%-5.1%+1.0%-3.2%
6M-1.6%+14.1%-15.7%-4.7%
YTD+2.6%-11.9%+14.5%+4.7%
1Y+6.2%-5.1%+11.3%+6.5%
3Y+55.0%+44.3%+10.6%+39.6%
5Y+42.8%+3.1%+39.7%+37.4%
10Y+102.1%+159.6%-57.5%+61.9%
All+102.1%+158.9%-56.8%+61.9%

Cumulative growth

Daily Returns

Daily percentage return beside SSNC.

Daily Out/Under-Performance

Portfolio return minus SSNC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SSNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded SSNC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling